About UsServices
· Market Intelligence· Strategy & Growth· Trade & Execution
Industries
· Healthcare· FMCG· Sustainability
Insights
· Articles· Blogs· Case Studies
CareersContact
Case Studies

Outcomes we've engineered

Selected engagements and the measurable impact they produced — from market expansion to opportunity mapping across healthcare, life sciences and FMCG.

10 Studies
All Case Studies
Diagnostics

Sizing a Niche Healthcare Market in 3 Weeks: A Pre-Feasibility Case Study

A medical device startup had early clinical validation for a diagnostic device but no clear read on commercial viability. Cap7tara delivered a pre-feasibility market-sizing study in three weeks, giving the founders the numbers they needed to decide whether to proceed to a funding round.

₹340 Cr
Total addressable market sized
18%
Projected 5-year CAGR
3 weeks
Kickoff to feasibility report
Personal Care & Beauty

Category Deep-Dive: Who's Winning in India's Personal Care Market and Why

An investor evaluating a personal care acquisition needed an independent view of category dynamics beyond the target's own data room. Cap7tara's category study gave the investment committee a clear read on who was actually winning share, and why.

7
Brands benchmarked head-to-head
3 factors
Explained ~80% of observed share shifts
5 weeks
Scoping to investment-committee readout
Personal Care & Beauty

De-risking a New FMCG Product Launch: A Pre-Launch Research Playbook

A D2C-only personal care startup was preparing to move into physical retail for the first time and wanted to avoid launching a SKU mix that wouldn't sell off-platform. Cap7tara's pre-launch research playbook flagged the changes needed before the client committed to a print run

3 of 8
SKUs flagged as retail-unready
45%
Price gap vs. category norm identified
4 weeks
Concept test to launch-ready SKU list
FMCG

Reverse-Engineering a Competitor's Shelf Strategy: A Retail Category Study

A challenger snacks brand was losing shelf space to a dominant competitor and couldn't tell whether it was a pricing problem, a trade-margin problem, or a retailer-relationship problem. Cap7tara's retail audit isolated the real driver and gave the client a concrete negotiation playbook.

120
Retail outlets audited across 3 cities
4.2x
Competitor's average shelf-facing advantage
5 weeks
Audit design to negotiation playbook
Personal Care & Beauty

What 500+ Consumers Told Us About Shampoo Buying Behavior in Tier-2 India

A shampoo brand strong in metro modern trade wanted to understand whether its messaging and price architecture would work in tier-2 cities before committing to a distribution build-out. Cap7tara ran a 500+ respondent study that reshaped the brand's go-to-market pitch.

500+
Consumers surveyed across 6 cities
62%
Cited price-per-use over brand name
4 weeks
Fieldwork to insight report
FMCG

From 0 to 200 Qualified Leads: FMCG Decision-Maker Outreach in 30 Days

A supplier to FMCG manufacturers had a strong product but no structured way to reach category heads and procurement decision-makers. Cap7tara designed and ran a targeted outbound lead-generation engine that delivered a qualified, sales-ready pipeline within 30 days.

200+
Qualified decision-maker leads
34%
Response rate on first touch (after iteration)
30 days
Build to fully qualified pipeline
Pharma & Biotech

Unlocking Growth in Targeted Oncology Therapy

An established pharmaceutical company with a targeted oncology portfolio had hit a growth ceiling across four markets. Cap7tara delivered a market expansion framework that enabled entry into two new markets and raised prescription share by 4 percentage points — within an 8-week engagement.

4→6
Active markets
+4pp
Prescription share
10-12%
YoY growth
Life Sciences

Global Laboratory Chemical Market: $2.1B Opportunity Mapped

A global life sciences leader was planning reactively in a market growing at 11.8% CAGR. 4,200+ primary interactions across 18 countries. Six priority categories. $2.1B in incremental opportunity identified. Execution began within 60 days of delivery.

$2.1B
Opportunity identified
4,200+
Primary interactions
18
Countries covered
Healthcare

Decoding the $20B AI Radiology Market

Seven strategic uncertainties resolved. Board-level investment case built. Entry wedge identified in emergency triage and oncology imaging — the two highest ROI-density segments in a rapidly consolidating market.

28%
CAGR 2024–2029
$20.4B
Market by 2029
7
Uncertainties resolved

Have a decision that needs evidence?